Search research articles
Contact Us
Filters
Showing results (241-250 of 418) with videos related to
Page
of 42
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 16, 2019
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
Aine O'Reilly, Peta Hughes, Jasmine Mann, et al.
Molecular Cancer Therapeutics
|
October 22, 2015
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Victoria L Bridgeman, Elaine Wan, Shane Foo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2017
Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III
Jean Jacques Grob, Dirk Schadendorf, Paul Lorigan, et al.
Genome Research
|
December 21, 2011
Whole genome sequencing of matched primary and metastatic acral melanomas
Samra Turajlic, Simon J Furney, Maryou B Lambros, et al.
Cancer Discovery
|
February 22, 2024
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma
Toni K Choueiri, Amber C Donahue, David A Braun, et al.
Cancer Immunology Research
|
August 14, 2021
TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma
F Stephen Hodi, Jedd D Wolchok, Dirk Schadendorf, et al.
European Urology Oncology
|
September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions
Laura Marandino, Riccardo Campi, Daniele Amparore, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2023
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
Drew W Rasco, Theresa Medina, Pippa Corrie, et al.
Journal for Immunotherapy of Cancer
|
November 20, 2021
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067
Meredith M Regan, Charlene M Mantia, Lillian Werner, et al.
Molecular Cancer Research : MCR
|
January 21, 2026
Contrasting features of papillary and chromophobe renal cell carcinoma revealed by whole genome sequencing
Richard Culliford, Charlie Mills, Daniel Chubb, et al.
Page
of 42
Search research articles
Search
Showing results (241-250 of 418) with videos related to
Sort By:
Page
of 42
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 16, 2019
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors
Aine O'Reilly, Peta Hughes, Jasmine Mann, et al.
Molecular Cancer Therapeutics
|
October 22, 2015
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
Victoria L Bridgeman, Elaine Wan, Shane Foo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 12, 2017
Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III
Jean Jacques Grob, Dirk Schadendorf, Paul Lorigan, et al.
Genome Research
|
December 21, 2011
Whole genome sequencing of matched primary and metastatic acral melanomas
Samra Turajlic, Simon J Furney, Maryou B Lambros, et al.
Cancer Discovery
|
February 22, 2024
Integrative Analyses of Tumor and Peripheral Biomarkers in the Treatment of Advanced Renal Cell Carcinoma
Toni K Choueiri, Amber C Donahue, David A Braun, et al.
Cancer Immunology Research
|
August 14, 2021
TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced Melanoma
F Stephen Hodi, Jedd D Wolchok, Dirk Schadendorf, et al.
European Urology Oncology
|
September 26, 2024
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions
Laura Marandino, Riccardo Campi, Daniele Amparore, et al.
Cancer Chemotherapy and Pharmacology
|
May 23, 2023
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma
Drew W Rasco, Theresa Medina, Pippa Corrie, et al.
Journal for Immunotherapy of Cancer
|
November 20, 2021
Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067
Meredith M Regan, Charlene M Mantia, Lillian Werner, et al.
Molecular Cancer Research : MCR
|
January 21, 2026
Contrasting features of papillary and chromophobe renal cell carcinoma revealed by whole genome sequencing
Richard Culliford, Charlie Mills, Daniel Chubb, et al.
Page
of 42